Ameliorating Cognitive Control in Binge Eating Disorder
NCT ID: NCT04572087
Last Updated: 2022-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2020-09-08
2022-03-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuromodulation with Attention Bias Modification Training for Binge Eating Disorder
NCT04424745
Effect of Nutritional Counseling Associated With Transcranial Direct-current Stimulation in Binge Eating Reduction
NCT04226794
The Effects of Repetitive Transcranial Magnetic Stimulation in Obese People With BED
NCT02180984
Transcranial Magnetic Stimulation and Inhibitory Control Training to Reduce Binge Eating: Brain and Behavioral Changes
NCT06649994
Guided Self-Help Treatment for Binge Eating Disorder
NCT00158340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
o Sample size: We will allocate 40 patients in the trial, i.e. 20 patients in each study arm.
o Recruitment: Patients are recruited by announcements, mails to the distributor list of the university hospital, existing databases of patients, and current patients of the university hospital. Patients are screened by a standardized checklist. In- and exclusion criteria are checked during the screening procedure and during the baseline diagnostic before randomisation.
o Standard Operating Procedures: For the recruitment, diagnostic and experimental sessions, Standard Operating Procedures are documented for the experimenter. This includes the order of clinical interviews, questionnaires and operating with the technical measurement instruments. The experimenters are regularly supervised. All adverse events will be listed and severe adverse events will be reported immediately to the PIs.
o Quality assurance plan: Randomized allocation to the stimulation condition (verum vs. sahm) and statistical analyses is done externally by the Institute of Clinical Epidemiology and Applied Biometry, University Tübingen, Germany (ICEAB). Objective technical measurement instruments are mostly used to record data.
o Data checks: Data is recorded mostly by objective technical measurement instruments, so no external monitoring is needed. We will spot check entered questionnaire data, in particular binge eating frequency in the past four weeks will be double checked as this is the primary outcome (PO).
o Source data verification: Data are spot checked by comparing the entries in the source data with the entries in the database. Each PO entry will be double checked. There are pre-defined criteria for entering data into the database.
* Data dictionary:
A data dictionary that contains detailed descriptions of each variable and how to be entered is available.
o Plan for missing data: Missing data and invalid data as well as the reasons will be recorded.
o Statistical analysis plan: A mixed model approach will be used to analyze the PO and secondary outcomes (SOs).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
After the six training sessions within 2 weeks a post measurement concerning task performance (T7) without tDCS takes place. 4 Weeks after treatment, the diagnostic post measurement (T8) will be executed. 3 months later, a follow-up via phone (T9) will be done.
TREATMENT
QUADRUPLE
The PIs and the biostatistician from the external ICEAB who is doing the statistical analysis are blinded as well until the end of the analysis.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Control Training + Verum stimulation
This arm consists of the cognitive control training (six sessions) combined with 2mA anodal tDCS over the right dlPFC (F4) during the training for 20 minutes.
Behavioral training and verum stimulation
Cognitive control training and verum tDCS
Cognitive Control Training + Sham stimulation
This arm consists of cognitive control training (six sessions) with sham-tDCS. 2 mA Sham-tDCS (40 seconds of tDCS) is applied to the right dlPFC (F4) before the trainings starts.
Behavioral training and sham stimulation
Cognitive control training and sham tDCS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral training and verum stimulation
Cognitive control training and verum tDCS
Behavioral training and sham stimulation
Cognitive control training and sham tDCS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Legal age
* BMI above 20 kg/m2
Exclusion Criteria
* Current pregnancy or lactation period
* Current or lifetime psychotic disorder, bipolar-I disorder, current substance dependence, suicidality
* Past bariatric surgery
* Severe physical disease which influence weight or eating behaviour (e.g. severe diabetes) or neurologic disease
* Non-removable metal parts in the area of the head
* Pacemaker
* Neuroleptics and benzodiazepine
* impaired vision, ametropia, eye diseases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof. Dr. Katrin Giel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Katrin Giel
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katrin E Giel, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tübingen
Christian Plewnia, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tübingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Tübingen
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Max SM, Plewnia C, Zipfel S, Giel KE, Schag K. Combined antisaccade task and transcranial direct current stimulation to increase response inhibition in binge eating disorder. Eur Arch Psychiatry Clin Neurosci. 2021 Feb;271(1):17-28. doi: 10.1007/s00406-020-01164-5. Epub 2020 Jul 13.
Schag K, Ince B, Zipfel S, Max S, Plewnia C, Giel K. [Non-Invasive Brain Stimulation in the Treatment of Eating Disorders - A Narrative Review]. Psychother Psychosom Med Psychol. 2020 Jun;70(6):246-251. doi: 10.1055/a-1156-8899. Epub 2020 Jun 9. German.
Giel KE, Schag K, Martus P, Max SM, Plewnia C. Ameliorating cognitive control in patients with binge eating disorder by electrical brain stimulation: study protocol of the randomized controlled ACCElect pilot trial. J Eat Disord. 2022 Feb 19;10(1):26. doi: 10.1186/s40337-022-00544-7.
Related Links
Access external resources that provide additional context or updates about the study.
research information of the University Tübingen, Germany
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PL 525/7-1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
GI 878/4-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.